105 related articles for article (PubMed ID: 26645402)
1. Impact of dexrazoxane on doxorubicin-induced aneuploidy in somatic and germinal cells of male mice.
Attia SM; Ahmad SF; Bakheet SA
Cancer Chemother Pharmacol; 2016 Jan; 77(1):27-33. PubMed ID: 26645402
[TBL] [Abstract][Full Text] [Related]
2. Dexrazoxane mitigates epirubicin-induced genotoxicity in mice bone marrow cells.
Attia SM; Ahmad SF; Saquib Q; Harisa GI; Al-Khedhairy AA; Bakheet SA
Mutagenesis; 2016 Mar; 31(2):137-45. PubMed ID: 26399706
[TBL] [Abstract][Full Text] [Related]
3. Dexrazoxane Averts Idarubicin-Evoked Genomic Damage by Regulating Gene Expression Profiling Associated With the DNA Damage-Signaling Pathway in BALB/c Mice.
Attia SM; Alshahrani AY; Al-Hamamah MA; Attia MM; Saquib Q; Ahmad SF; Ansari MA; Nadeem A; Bakheet SA
Toxicol Sci; 2017 Nov; 160(1):161-172. PubMed ID: 28973540
[TBL] [Abstract][Full Text] [Related]
4. Comparative aneugenicity of doxorubicin and its derivative idarubicin using fluorescence in situ hybridization techniques.
Attia SM
Mutat Res; 2011 Oct; 715(1-2):79-87. PubMed ID: 21856314
[TBL] [Abstract][Full Text] [Related]
5. Orthovanadate increased the frequency of aneuploid mouse sperm without micronucleus induction in mouse bone marrow erythrocytes at the same dose level.
Attia SM; Badary OA; Hamada FM; de Angelis MH; Adler ID
Mutat Res; 2005 Jun; 583(2):158-67. PubMed ID: 15886051
[TBL] [Abstract][Full Text] [Related]
6. Influence of resveratrol on oxidative damage in genomic DNA and apoptosis induced by cisplatin.
Attia SM
Mutat Res; 2012 Jan; 741(1-2):22-31. PubMed ID: 22063162
[TBL] [Abstract][Full Text] [Related]
7. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
Seymour L; Bramwell V; Moran LA
Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
[TBL] [Abstract][Full Text] [Related]
8. Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cells.
Bakheet SA; Attia SM; Al-Rasheed NM; Al-Harbi MM; Ashour AE; Korashy HM; Abd-Allah AR; Saquib Q; Al-Khedhairy AA; Musarrat J
Mutagenesis; 2011 Jul; 26(4):533-43. PubMed ID: 21430063
[TBL] [Abstract][Full Text] [Related]
9. Molecular cytogenetic evaluation of the aneugenic effects of teniposide in somatic and germinal cells of male mice.
Attia SM
Mutagenesis; 2012 Jan; 27(1):31-9. PubMed ID: 21821840
[TBL] [Abstract][Full Text] [Related]
10. Protection of mouse bone marrow from etoposide-induced genomic damage by dexrazoxane.
Attia SM; Al-Anteet AA; Al-Rasheed NM; Alhaider AA; Al-Harbi MM
Cancer Chemother Pharmacol; 2009 Sep; 64(4):837-45. PubMed ID: 19184016
[TBL] [Abstract][Full Text] [Related]
11. Dexrazoxane exacerbates doxorubicin-induced testicular toxicity.
Levi M; Tzabari M; Savion N; Stemmer SM; Shalgi R; Ben-Aharon I
Reproduction; 2015 Oct; 150(4):357-66. PubMed ID: 26329125
[TBL] [Abstract][Full Text] [Related]
12. Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms.
Deng S; Yan T; Jendrny C; Nemecek A; Vincetic M; Gödtel-Armbrust U; Wojnowski L
BMC Cancer; 2014 Nov; 14():842. PubMed ID: 25406834
[TBL] [Abstract][Full Text] [Related]
13. Proanthocyanidins produce significant attenuation of doxorubicin-induced mutagenicity via suppression of oxidative stress.
Attia SM; Al-Bakheet SA; Al-Rasheed NM
Oxid Med Cell Longev; 2010; 3(6):404-13. PubMed ID: 21311213
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress does not play a primary role in the toxicity induced with clinical doses of doxorubicin in myocardial H9c2 cells.
Rharass T; Gbankoto A; Canal C; Kurşunluoğlu G; Bijoux A; Panáková D; Ribou AC
Mol Cell Biochem; 2016 Feb; 413(1-2):199-215. PubMed ID: 26833193
[TBL] [Abstract][Full Text] [Related]
15. Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice.
Vijay V; Moland CL; Han T; Fuscoe JC; Lee T; Herman EH; Jenkins GR; Lewis SM; Cummings CA; Gao Y; Cao Z; Yu LR; Desai VG
Toxicol Appl Pharmacol; 2016 Mar; 295():68-84. PubMed ID: 26873546
[TBL] [Abstract][Full Text] [Related]
16. Dexrazoxane abrogates acute doxorubicin toxicity in marmoset ovary.
Salih SM; Ringelstetter AK; Elsarrag MZ; Abbott DH; Roti EC
Biol Reprod; 2015 Mar; 92(3):73. PubMed ID: 25609833
[TBL] [Abstract][Full Text] [Related]
17. Comet-FISH studies for evaluation of genetic damage of citalopram in somatic cells of the mouse.
Attia SM; Ashour AE; Bakheet SA
J Appl Toxicol; 2013 Sep; 33(9):901-5. PubMed ID: 23400819
[TBL] [Abstract][Full Text] [Related]
18. Effect of dihydrokainate on the capacity of repair of DNA damage and apoptosis induced by doxorubicin.
Attia SM; Bakheet SA
Mutagenesis; 2013 May; 28(3):257-61. PubMed ID: 23360835
[TBL] [Abstract][Full Text] [Related]
19. Acute dosage with dexrazoxane, but not doxorubicin, is associated with increased rates of hepatic protein synthesis in vivo.
Zima T; Tesar V; Sherwood R; Sood A; Au LC; Richardson PJ; Preedy VR
Toxicol Pathol; 2001; 29(6):591-9. PubMed ID: 11794374
[TBL] [Abstract][Full Text] [Related]
20. Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicity.
Pearlman M; Jendiroba D; Pagliaro L; Keyhani A; Liu B; Freireich EJ; Travis E
Cancer Chemother Pharmacol; 2003 Dec; 52(6):477-81. PubMed ID: 12827292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]